Bladder Breast Hematologic Leukemia Lymphoma Multiple
Myeloma Myelodysplastic Syndrome Pancreatic Urologic
Not exact matches
About one - half (45 %) of patients were enrolled in lymphoma trials, one - quarter (24 %) in chronic myeloid leukemia (CML) trials or multiple
myeloma trials (22 %), and 2 % of patients were enrolled in trials of acute myeloid leukemia (AML) or
myelodysplastic syndrome (MDS).
In some cases, blood cancers — leukemia,
myelodysplastic syndrome (MDS), lymphoma and multiple
myeloma — are related to inherited genetic factors.
FDA Clears Test to Help Diagnose, Identify Blood Cancer Type: The FDA has approved ClearLLab Reagents (T1, T2, B1, B2, M) for the detection of hematologic malignancies such as acute and chronic leukemias,
myelodysplastic syndromes, myeloproliferative neoplasms, multiple
myeloma, and non-Hodgkin lymphoma.